Oncologic Patients | List of Frontiers open access articles

Original Research

Published on 07 Oct 2025

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients

in NK and Innate Lymphoid Cell Biology

Gabirel Astarloa-Pando
Victor Sandá
Ainhoa Amarilla-Irusta
Ainara Lopez-Pardo
Itxaso San Juan
Ainhoa Iturbe-Larrondo
Raquel Pérez-Garay
Silvia Pérez-Fernández
Borja Santos-Zorrozúa
Bárbara Manzanares-Martín

Frontiers in Immunology

doi 10.3389/fimmu.2025.1629118

4,324 views

Community Case Study

Published on 16 Jun 2022

Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents

in Drug, Venom & Anaphylaxis

Julián Borrás Cuartero
Roxana Farzanegan Miñano
María Cruz Torres Gorriz
Adrián Germán Sánchez
Raquel Cervera Aznar
Isabela Raducan
Jose Vicente Castelló Carrascosa
Alfredo Sanchez Hernandez
Ernesto Enrique

Frontiers in Allergy

doi 10.3389/falgy.2022.868300

3,416 views
4 citations

Original Research

Published on 27 Apr 2022

A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients

in Cancer Imaging and Image-directed Interventions

Dania Cioni
Michela Gabelloni
Andrea Sanguinetti
Laura De Rosa
Giacomo Aringhieri
Rachele Tintori
Gianvito Candita
Maria Febi
Francesco Faita
Riccardo Lencioni

Frontiers in Oncology

doi 10.3389/fonc.2022.873524

2,558 views

Original Research

Published on 10 Oct 2023

CritCom: assessment of quality of interdisciplinary communication around deterioration in pediatric oncologic patients

in Pediatric Oncology

Jocelyn Rivera
Sara Malone
Maria Puerto-Torres
Kim Prewitt
Lara Counts
Parima Wiphatphumiprates
Firas Sakaan
Zebin Al Zebin
Anita V. Arias
Parthasarathi Bhattacharyya

Frontiers in Oncology

doi 10.3389/fonc.2023.1207578

4,029 views
2 citations

Editorial

Published on 22 Jul 2021

Editorial: Surgery and COVID-19: Which Strategies to Apply in Oncologic Patients

in Surgical Oncology

Ugo Cioffi
Michele M. Ciulla
Matilde De Simone
Marco Scarci
Alberto Testori
Federico Raveglia
Marco Chiarelli

Frontiers in Surgery

doi 10.3389/fsurg.2021.718751

3,631 views
1 citation

Perspective

Published on 10 Jul 2020

Seven Shades of Black Thoughts: COVID-19 and Its Psychological Consequences on Cancer Patients

in Cancer Epidemiology and Prevention

Mattia Garutti
Francesco Cortiula
Fabio Puglisi

Frontiers in Oncology

doi 10.3389/fonc.2020.01357

6,164 views
19 citations

Brief Research Report

Published on 02 Nov 2022

Exploring the influence of takotsubo syndrome on oncologic patients’ mortality

in Cardio-Oncology

Giacomo Tini
Luca Arcari
Matteo Sclafani
Paolo Spallarossa
Giovanni Camastra
Allegra Battistoni
Camillo Autore
Massimo Volpe
Beatrice Musumeci
Pietro Ameri

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1020078

1,842 views
4 citations

Original Research

Published on 09 Jan 2023

Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients

in Viral Immunology

Flávio Pignataro-Oshiro
Amanda B. Figueiredo
Nayane A. L. Galdino
Katia L. P. Morais
Walderez O. Dutra
Bianca Grassi de Miranda Silva
Diego Feriani
Flávia de Azevedo Abrantes
Ivan Leonardo Avelino França e Silva
Jayr Schmidt Filho

Frontiers in Immunology

doi 10.3389/fimmu.2022.1052104

4,365 views
2 citations

Review

Published on 23 Jan 2023

Sulforaphane: An emergent anti-cancer stem cell agent

in Cancer Molecular Targets and Therapeutics

Leandro de Lima Coutinho
Tharcísio Citrangulo Tortelli Junior
Maria Cristina Rangel

Frontiers in Oncology

doi 10.3389/fonc.2023.1089115

38,172 views
41 citations

Review

Published on 28 Oct 2021

Targeting Phosphatases and Kinases: How to Checkmate Cancer

in Signaling

Alice Turdo
Caterina D’Accardo
Antonino Glaviano
Gaetana Porcelli
Cristina Colarossi
Lorenzo Colarossi
Marzia Mare
Naida Faldetta
Chiara Modica
Giuseppe Pistone

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.690306

13,602 views
55 citations

Original Research

Published on 11 Aug 2023

Oral fibroblasts rescue osteogenic differentiation of mesenchymal stem cells after exposure to Zoledronic acid in a paracrine effect

in Translational Pharmacology

Tal Berg
Ofri Doppelt-Flikshtain
Benjamin R. Coyac
Hadar Zigdon-Giladi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172705

2,771 views
4 citations

Systematic Review

Published on 03 Feb 2022

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review

in Obstetric and Pediatric Pharmacology

Kristopher Amaro-Hosey
Immaculada Danés
Antònia Agustí

Frontiers in Pharmacology

doi 10.3389/fphar.2021.777498

6,079 views
10 citations

Original Research

Published on 21 Oct 2021

Cause of Death in Patients in Radiation Oncology

in Radiation Oncology

Justus Domschikowski
Karoline Koch
Claudia Schmalz

Frontiers in Oncology

doi 10.3389/fonc.2021.763629

11,496 views
2 citations

Case Report

Published on 07 Mar 2024

Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Valérian Rivet
Vincent Sibaud
Jérémie Dion
Thibaut Volosov
Mélanie Biteau
Andréa Pastissier
Karen Delavigne
Pierre Cougoul
Odile Rauzy
Thibault Comont

Frontiers in Oncology

doi 10.3389/fonc.2024.1353896

2,878 views
4 citations

Brief Research Report

Published on 20 Jun 2024

Scope of services provided to childhood cancer patients by the Brazilian Pediatric Palliative Care Network

in Pediatric Oncology

Esther Angélica Luiz Ferreira
Cristina Ortiz Sobrinho Valete
Silvia Maria de Macedo Barbosa
Graziela de Araujo Costa
Poliana Cristina Carmona Molinari
Ana Cristina Pugliese de Castro
Simone Brasil de Oliveira Iglesias
Maycon Rodrigo Sarracini
Rodrigo Bezerra de Menezes Reiff
Cristina Helena Bruno

Frontiers in Oncology

doi 10.3389/fonc.2024.1376631

3,042 views
1 citation

Original Research

Published on 30 May 2024

Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms

in Translational Pharmacology

Jorge Berlanga-Acosta
Danay Cibrian
Juan Valiente-Mustelier
José Suárez-Alba
Ariana García-Ojalvo
Viviana Falcón-Cama
Baohong Jiang
Linlin Wang
Gerardo Guillén-Nieto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402138

10,461 views
9 citations

Articles

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients

Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents

A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients

CritCom: assessment of quality of interdisciplinary communication around deterioration in pediatric oncologic patients

Editorial: Surgery and COVID-19: Which Strategies to Apply in Oncologic Patients

Seven Shades of Black Thoughts: COVID-19 and Its Psychological Consequences on Cancer Patients

Exploring the influence of takotsubo syndrome on oncologic patients’ mortality

Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients

Sulforaphane: An emergent anti-cancer stem cell agent

Targeting Phosphatases and Kinases: How to Checkmate Cancer

Oral fibroblasts rescue osteogenic differentiation of mesenchymal stem cells after exposure to Zoledronic acid in a paracrine effect

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review

Cause of Death in Patients in Radiation Oncology

Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review

Scope of services provided to childhood cancer patients by the Brazilian Pediatric Palliative Care Network

Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms